Radboud University Medical Center: Ischemia trials

The registry lists 17 Ischemia studies with Radboud University Medical Center as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 1Phase 4 7No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDiumCompletedNCT02118753Not applicable
• Primary Hyperaldosteronism and Ischemia-reperfusion InjuryCompletedNCT01978132Not applicable
• Effect of Tea on Endothelial Function and Ischaemia-reperfusion InjuryCompletedNCT01660516
• The Metformin-FMD TrialCompletedNCT01610401Phase 4
• Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?CompletedNCT01295567Phase 4
• Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion InjuryCompletedNCT00987974Phase 4
• Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?CompletedNCT00457652Phase 4
• Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?CompletedNCT00457405Phase 4
• Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm ExerciseWithdrawnNCT00441714Not applicable
• Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?CompletedNCT00441597Phase 4
• Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?CompletedNCT00430170Phase 4
• The Influence of the 34C>T Variant in the AMPD1 Gene Ischemic ToleranceCompletedNCT00319059Not applicable
• Rosuvastatin and Ischemia ReperfusionCompletedNCT00315510Phase 2
• Opioid Receptors Influence Ischemia-Reperfusion InjurySuspendedNCT00184938Not applicable
• The Effect of Caffeine on Ischemic PreconditioningCompletedNCT00184912Not applicable
• Adenosine Receptors Influence Ischemia-Reperfusion InjurySuspendedNCT00184847Not applicable
• Ischemic Injury and Ischemic Preconditioning in DiabetesCompletedNCT00184821